← The Wire
TARANasdaq
Protara Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · CIK 1359931
Advancing transformative cell therapies and phospholipid substrate replacement therapies for cancer and rare diseases
red 8-K · 90d
$219M
Market cap
$4.16
Last close
+1.0%
1D
+1.2%
5D
989K
Volume
Price · last 39 sessions-23.7%
May 4L $3.65 · H $5.66Jun 29
244
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
DEF 14APROXY STATEMENTApr 28, 2026DEF 14APROXY STATEMENTApr 25, 2025DEF 14APROXY STATEMENTApr 26, 2024DEF 14APROXY STATEMENTApr 26, 2023DEF 14ADEFINITIVE PROXY STATEMENTApr 27, 2022DEF 14ADEFINITIVE PROXY STATEMENTApr 27, 2021DEF 14ADEFINITIVE PROXY STATEMENTApr 23, 2020DEF 14ADEFINITIVE PROXY STATEMENTApr 26, 2018DEF 14ADEFINITIVE PROXY STATEMENTJul 13, 2017DEF 14ADEF 14AApr 27, 2017DEF 14ADEFINITIVE PROXY STATEMENTApr 20, 2016DEF 14ADEFINITIVE PROXY STATEMENTApr 21, 2015
Similar companies
Comparable business profile · signals at a glance